5th Annual MarketsandMarkets

Biomarker and Companion Diagnostics Conference

February 6th -7th, 2020

Sheraton San Diego Hotel & Marina, 1380 Harbor Island Dr, CA 92101, United States

30+

Speaker

10+

Networking Hours

4+

Sessions

200+

Attendees

The 5th Annual Biomarker and Companion Diagnostics Conference scheduled to be held on 6th - 7th February 2020 in San Diego, CA would address the gaps between early-stage biomarker development and the commercialization stage of biomarkers. This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data. Regarding the commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in the companion diagnostics areas. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

Tag Line
30+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, Impact of Big data in translational biomarker research and Future of Companion Diagnostics
Tag Line
Opportunity to develop long-lasting business relationships and networking opportunities with researchers, scientists, clinicians, academicians and professionals from Pharmaceutical companies, Bio-pharma companies, Universities, and Research institutes.
Tag Line
Over 20 presentations, round-tables, and panel discussions focused on the key opportunities and challenges in biomarker research, from precision medicine and companion diagnostics through to digital biomarkers and clinical trials.

This two-day event will invite 200+ biomarker discovery professionals, 30+ expert speakers and 15+ solution/technology providers to a unique platform to deliver niche buyer-seller ecosystem in the biomarker Industry.

WHAT TO EXPECT

Researchers, Scientists & Clinicians who are active in:

  • Biomarker discovery/development
  • Translational research
  • Clinical Biomarker
  • Biomarkers in IO and Neurological disorders
  • Imaging Biomarkers
  • Companion Diagnostics
  • Biomarker Imaging
  • Proteomics Biomarkers
  • Experimental Medicine
  • Data Science
  • Biomarkers in Clinical Discovery
  • Immuno-oncology/Neuroscience Drug Discovery
  • Diagnostic Biomarkers development

  • Biomarker Drug Discovery and Assay Development
  • Proteomics and Genomics based Biomarkers
  • Digital Biomarkers, Precision Medicine and Big Data
  • Predictive Biomarkers in targeted Cancer Therapy
  • CDx development and Commercialization
  • Clinical Applications of Biomarkers in Immuno-Oncology
  • Neurology and Inflammatory Diseases

  • Biomarkers In Clinical & Translational Development: Drug Discovery And Assay Development
  • Innovations In Biomarker Research: Digital Biomarkers, Precision Medicine And Big Data
  • From Biomarkers To Cdx: Strategies To Accelerate Cdx Development And Commercialization
  • Clinical Applications Of Biomarkers In Immuno-oncology, Neurology And Inflammatory Diseases

 

CONFERENCE AGENDA

Registration

08:15 - 08:45

Welcome note from MarketsandMarkets

Shekhar Gupta

Shekhar Gupta , Geography Head-US, MarketsandMarkets

08:45 - 09:05

Opening Remarks from the Chairman

Naveen Babbar

Naveen Babbar , Executive Director, Precision Medicine Leader, Novartis

09:05 - 09:10

Keynote Presentation

Lokesh Agrawal

Lokesh Agrawal , Program Director, Biorepositories and Biospecimen Research Branch (BBRB), , NIH

09:10 - 09:40

BIOMARKERS IN CLINICAL & TRANSLATIONAL DEVELOPMENT: DRUG DISCOVERY AND ASSAY DEVELOPMENT

New Directions in Biomarkers for CAR-T Therapies in Multiple Myeloma

Majid Ghoddusi

Majid Ghoddusi , Senior Director, Clinical Biomarkers, Poseida Therapeutics

09:40 - 10:10

Non-invasive Precision Genomics in Dermatology

Burkhard Jansen

Burkhard Jansen , Chief Medical Officer , Dermtech

10:10 - 10:25

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:25 - 11:10

Enhanced Biomarker Discovery and Validation Using TMT® Proteomics

Jessica McDonough

Jessica McDonough, Co-Founder, Attivare Therapeutics

11:10 - 11:40

Interpreting the complexity of cancer with blood-based biomarkers for both tumor and immune profiling

Linda Traylor

Linda Traylor , Vice President, Clinical Development & Medical Affairs, Biodesix

11:40 - 12:10

Blood-based Traumatic Brain Injury Biomarkers: past, present and future

Kevin Wang

Kevin Wang, Director, Program for Neuroproteomics and Biomarkers Research, University of Florida

12:10 - 12:40

Streamlined CDx® Program - Accelerating Drug Approvals Worldwide

Jeffrey Miller

Jeffrey Miller, CSO & CEO, Invivoscribe

12:40 - 13:10

Lunch and Poster Presentation | One-to-One Networking Meetings

13:10 - 14:10

INNOVATIONS IN BIOMARKER RESEARCH: DIGITAL BIOMARKERS, PRECISION MEDICINE AND BIG DATA

Precision Medicine and Immuno-Oncology Drug Development

14:10 - 14:40

AI For Digital Biomarker Discovery

Christelle Fasano

Christelle Fasano, Senior Director, Business Development, Pharma & Biotech, Imagia

14:40 - 14:55

Business of Fit-for-Purpose: From Sample Management to Validation to Final Sample Analysis Data

Amber Donahue

Amber Donahue, Biomarker Clinical Assay Lead, Pfizer

14:55 - 15:25

Empowering Patients & Physicians: A Novel Clinical Trial for Molecular Disease Characterization

Kristin Blouch

Kristin Blouch, Director, Head of RWE & Molecular Disease Characterization, Experimental Medicine Unit, GSK

15:25 - 15:55

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:55 - 16:40

Using complex genetic/biomarker information to optimize trial design and developing efficient statistical algorithms to identify patient subgroups with better/worse responses/survival profile to a particular treatment

Vicky Wu

Vicky Wu, Co-Investigator, Fred Hutch

16:40 - 17:10

Developing global and gene specific methylation tools for drug development

17:10 - 17:25

Panel Discussion: Biomarker strategies and partnering with medical device companies

Karina Besprosvan

Karina Besprosvan , Datastoryteller Insight & Innovation Exponential C, Sony Pictures Entertainment

17:25 - 17:55

Closing Remarks from the Chairman

17:55 - 18:00

Drinks Reception & Networking

18:00 - 19:00

Registration

08:15 - 09:00

Welcome note from MarketsandMarkets

09:00 - 09:05

Opening Remarks from the Chairman

Majid Ghoddusi

Majid Ghoddusi , Senior Director, Clinical Biomarkers, Poseida Therapeutics

09:05 - 09:10

Keynote Presentation: Mechanisms of Toxicity, Resistance and Response to anti-CD19 CAR T cell Therapy in LCL

John Rossi

John Rossi, Vice President, Head, Translational Medicine, , Syncopation Lifesciences

09:10 - 09:40

FROM BIOMARKERS TO CDX: STRATEGIES TO ACCELERATE CDX DEVELOPMENT AND COMMERCIALIZATION

An Integrated Oncology Platform for Biomarker Discovery and Companion Diagnostics Development

Nicole Niu

Nicole Niu , Executive Director , Crown Bioscience

09:40 - 10:10

Tempus | Making the Promise of Precision Medicine a Reality

Michael Yasiejko

Michael Yasiejko , Chief Commercial Officer, Tempus

10:10 - 10:25

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:25 - 11:10

Integration of biomarker validation in clinical development: a statistical perspective

Elisabeth Coart

Elisabeth Coart, Director, Consulting Services, IDDI

11:10 - 11:40

Eutropics’ Praedicare DxTM platform providing predictive functional biomarkers for AML

Michael Cardone

Michael Cardone, CEO , Eutropics Pharmaceuticals Inc.

11:40 - 11:55

Accurate Plasma Biomarker Detection for Clinical Trials & Clinical Practice: Why Sensitivity Matters

Dan Edelstein

Dan Edelstein , Vice President, Commercial Operations, Sysmex Inostics

11:55 - 12:10

Companion Diagnostic Development in Gene Expression for Challenging Sample Types

BJ Kerns

BJ Kerns, Vice President, Scientific Collaborations , HTG Molecular Diagnostics

12:10 - 12:40

Companion Diagnostic Development: How to Ensure Program Success

Kristina McGuire

Kristina McGuire, Executive Director and Head of CDx & Lab Operations, Precision Medicine, Regeneron Pharmaceuticals

12:40 - 13:10

Lunch and Poster Presentation | One-to-One Networking Meetings

13:10 - 14:10

CLINICAL APPLICATIONS OF BIOMARKERS IN IMMUNO-ONCOLOGY, NEUROLOGY AND INFLAMMATORY DISEASES

Increasing Complexity in Tissue Based Diagnostics

Scott Boyer

Scott Boyer, Business Development Manager, Leica Biosystems

14:10 - 14:25

A universal early cancer screen using a blood-based 400K frameshift peptide array

Yisrael Katz

Yisrael Katz, Senior Medical Director , Viracta Therapeutics, Inc.

14:25 - 14:55

Immuno-Oncology Biomarkers Identified by Novel Digital Pathology Approaches

Jennifer Bordeaux

Jennifer Bordeaux , Principal Investigator, Navigate BioPharma

14:55 - 15:25

Targeting extrachromosomal DNA (ecDNA), a new approach to treating cancers with high copy number gene amplification

Jason Christiansen

Jason Christiansen, Chief Technology Officer, Boundless Bio

15:25 - 15:55

CONFERENCE SPEAKERS

ADVISORS

Steven Richards

Steven Richards

Investigator, Biomarker Expert, Novartis

Pallavi Sachdev

Pallavi Sachdev

Senior Director, Clinical Pharmacology and Translational Medicine, Eisai

Howard Federoff

Howard Federoff

Professor of Neurology, University of California

SPEAKERS

Shekhar Gupta

Shekhar Gupta

Geography Head-US, MarketsandMarkets

John Rossi

John Rossi

Vice President, Head, Translational Medicine, , Syncopation Lifesciences

Amber Donahue

Amber Donahue

Biomarker Clinical Assay Lead, Pfizer

Yisrael Katz

Yisrael Katz

Senior Medical Director , Viracta Therapeutics, Inc.

Naveen Babbar

Naveen Babbar

Executive Director, Precision Medicine Leader, Novartis

Vicky Wu

Vicky Wu

Co-Investigator, Fred Hutch

Elisabeth Coart

Elisabeth Coart

Director, Consulting Services, IDDI

Kevin Wang

Kevin Wang

Director, Program for Neuroproteomics and Biomarkers Research, University of Florida

Jason Christiansen

Jason Christiansen

Chief Technology Officer, Boundless Bio

Michael Cardone

Michael Cardone

CEO , Eutropics Pharmaceuticals Inc.

Nicole Niu

Nicole Niu

Executive Director , Crown Bioscience

Jessica McDonough

Jessica McDonough

Co-Founder, Attivare Therapeutics

BJ Kerns

BJ Kerns

Vice President, Scientific Collaborations , HTG Molecular Diagnostics

Kristin Blouch

Kristin Blouch

Director, Head of RWE & Molecular Disease Characterization, Experimental Medicine Unit, GSK

Michael Yasiejko

Michael Yasiejko

Chief Commercial Officer, Tempus

Burkhard Jansen

Burkhard Jansen

Chief Medical Officer , Dermtech

Karina Kulangara

Karina Kulangara

R&D Director, Companion Diagnostics, Agilent

Jennifer Bordeaux

Jennifer Bordeaux

Principal Investigator, Navigate BioPharma

Linda Traylor

Linda Traylor

Vice President, Clinical Development & Medical Affairs, Biodesix

Dan Edelstein

Dan Edelstein

Vice President, Commercial Operations, Sysmex Inostics

Jeffrey Miller

Jeffrey Miller

CSO & CEO, Invivoscribe

Scott Boyer

Scott Boyer

Business Development Manager, Leica Biosystems

Majid Ghoddusi

Majid Ghoddusi

Senior Director, Clinical Biomarkers, Poseida Therapeutics

Kristina McGuire

Kristina McGuire

Executive Director and Head of CDx & Lab Operations, Precision Medicine, Regeneron Pharmaceuticals

David Stanforth

David Stanforth

Head, IVD Strategy and Development, Amgen

Christelle Fasano

Christelle Fasano

Senior Director, Business Development, Pharma & Biotech, Imagia

Lokesh Agrawal

Lokesh Agrawal

Program Director, Biorepositories and Biospecimen Research Branch (BBRB), , NIH

ENQUIRE NOW

SPONSORS

PARTNERS

LOCATION

Venue

Sheraton San Diego Hotel & Marina, 1380 Harbor Island Dr, CA 92101, United States

PAST EVENT GALLERY